Patent foramen ovale closure in stroke patients with migraine in the CLOSE trial. The CLOSE‐MIG study

In young and middle-aged adults with PFO-associated cryptogenic stroke and migraine, PFO closure plus antiplatelet therapy did not reduce the mean annual number of migraine attacks compared to antiplatelet therapy alone, in migraine patients both with and without aura.